Levodopa Other names: L-dopa L-3,4-dihydroxyphenylalanine

Chemical formula: C₉H₁₁NO₄  Molecular mass: 197.188 g/mol  PubChem compound: 6047

Therapeutic indications

Levodopa is indicated for:

Parkinson's disease

Population group: only adults (18 years old or older)

Levodopa is indicated for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson's disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Levodopa is contraindicated in the following cases:

Nonselective monoamine oxidase (MAO) inhibitor

Non selective Monoamine Oxidase Inhibitors

Pregnancy

Pregnancy

Lactation

Lactation

Phaeochromocytoma

Phaeochromocytoma

Narrow-angle glaucoma

Angle-closure glaucoma

A previous history of neuroleptic malignant syndrome (NMS) and/or non-traumatic rhabdomyolysis

at least one of
Neuroleptic malignant syndrome
Non-traumatic rhabdomyolysis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈